They observed Rac1 activation in podocytes and SGK1 activation in the renal cortex in these mice, all of which were downregulated by Rac1 inhibition, suggesting the involvement of the Rac1-MR signaling pathway in DKD (Hirohama et al., 2021). Here, NR3C2 is linked to diabetic kidney disease.